334 replies to this topic

[ImmInst]

CME, GERN, FLIR, CAKE, COOL - Wednesday Notable Stocks with Volume at NASDAQ
Health Talk & You - 1 hour ago

by Yvonne Magtibay in Business on Nov 02, 2011 CME Group Inc. (NASDAQ: CME) fell -8.59%, to close at $251.88 and its overall traded volume was 1.53M shares during the last session the stock had ...

View the full article

[ImmInst]

Geron Corporation Reports 2011 Third Quarter Financial Results and Events
MarketWatch - 12 minutes ago

For the third quarter of 2011, the company reported a net loss of $19.5 million, or $0.16 per share, compared to $18.3 million, or $0.19 per share, for the comparable 2010 period. Net loss for the ...

View the full article

[ImmInst]

Geron (GERN) Posts Quarterly Earnings, Beats Estimates By $0.02 EPS
LocalizedUSA - 3 hours ago

Geron (GERN) announced its quarterly results on Thursday. The company reported ($0.16) earnings per share for the quarter, beating the Thomson Reuters consensus estimate of ($0.18) by $0.02. The ...

View the full article

[ImmInst]

10-Q: GERON CORP
Middle East North Africa Financial Network - 3 hours ago

(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Form 10-Q contains forward-looking statements that involve risks and ...

View the full article

[ImmInst]

Geron Down 2.1%, Shares Slide into the Red (GERN)
Financial News Network Online - 17 minutes ago

Geron (NASDAQ:GERN) is one of today's worst performing low-priced stocks, down 2.1% to $2.31 on 0.2x average daily volume.Thus far today, Geron has traded 275,000 shares, vs. average volume of 1.3 ...

View the full article

[ImmInst]

Stocks Report Results: (FIX), (GERN), (PXP), (TSE: REF), (WR)
Takeover Chatter - 3 hours ago

Comfort Systems Usa Inc (FIX) announced their most recent earnings results for the quarter ended in September 2011. Earnings came in at $0.14 per share compared to analyst estimates of $0.11 per ...

View the full article

[ImmInst]

INVESTORS LOOK TO LIGHTEN UP ON SHARES OF GERON, SHARES DOWN 2.9% (GERN)
Zacks.com - 1 hour ago

Nov 07, 2011 (SmarTrend® Spotlight via COMTEX) -- Geron (NASDAQ:GERN - Analyst Report) is one of today's worst performing low-priced stocks, down 2.9% to $2.31 on 0.2x average daily volume.Thus ...

View the full article

[ImmInst]

Zacks Investment Research Analysts Reiterate a "Neutral" Rating on Geron (GERN)
LocalizedUSA - 1 hour ago

Geron (NASDAQ: GERN)'s stock had its “neutral” rating reaffirmed by equities research analysts at Zacks Investment Research in a research note issued to investors on Monday. The analysts currently ...

View the full article

[ImmInst]

Analysts' Ratings: AGNC, CELG, CI, DNDN, DST, EFSC, ENR, GERN, GNW, HTH, ICON, IPG, PX, SMA, TER, VTR, WFM, WHR
Jags Report - 5 hours ago

Zacks Investment Research reiterated its “neutral” on shares of American Capital Agency Corp. (AGNC). The firm has a $29.00 price target on the stock. Piper Jaffray reiterated its “overweight” on ...

Analysts' Ratings Reiterations for November, 7th (AGNC, APEI, CELG, CSCO, DBLE, DISH, DNDN, DST, DTE, ENOC, ENR, FOSL, GERN, GNW, HOLX, HTH, ICON, IPG, LPSN, MRK, MRVL, PRTS, PX, REGN, SD, SMA, TER, TW, USU, VTR, WFM, WHR) - LocalizedUSA

View the full article

[ImmInst]

The Stem Cell Game Just Changed: CYTX, ACTC, & GERN Compared, Contrasted
SmallCap Network - 2 hours ago

By Bryan Murphy While the stem cell debate has subsided from its 2007 fervor, the underlying work in the arena hasn't. It - and the underlying politics - have changed though. Just ask the folks at ...

View the full article

[ImmInst]

Top 10 Small Cap Stocks with Highest Upside: ITT, CLWR, NAK, GERN, XRA, AMRN, VELT, NKTR, SODA, GBG (Nov 08, 2011)
China Analyst - 49 minutes ago

Below are the top 10 Small Cap stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price. ITT Corporation (NYSE:ITT) has ...

View the full article

[ImmInst]

Geron Reports $19.5M Net Loss In Q3, Says R&D Cost To Rise
Seeking Alpha - 1 hour ago

For Q3/11, Geron (GERN) last week reported a net loss of $19.5M, or $0.16 per share, compared with $18.3M, or $0.19 per share, for Q3/10. Revenue was $220K, compared with $546K for Q3/10. Revenue ...

View the full article

[ImmInst]

UPDATE: Rodman & Renshaw Lowers PT to $4 on Geron
Benzinga - 1 hour ago

By Joe Young A report from Rodman & Renshaw reiterates its Market Outperform rating and lowers its price target from $9 to $4 on Geron (NASDAQ: GERN). The report states, “…an analysis of other ...

Geron (GERN) Share Price Target Lowered to $4.00 by Rodman & Renshaw Analysts - LocalizedUSA

View the full article

[ImmInst]

NASDAQ Heavily traded Stocks -TQQQ, LAMR, CPWR, GERN, PNFP
Retirement Planning - 1 hour ago

by Jon Ray Moll on November 9, 2011 ProShares UltraPro QQQ (NASDAQ: TQQQ) soared 3.33%, to close at $81.21 and its overall traded volume was 1.08M shares during the last session the stock had ...

View the full article

[ImmInst]

Analysts' Ratings: CL, CRM, CRZO, DIOD, DOX, ENV, EPOC, ESE, ESSX, FC, FLDM, GEOI, GERN, GTAT, HALO
Jags Report - 3 hours ago

Zacks Investment Research reiterated its “neutral” on shares of Colgate-Palmolive Company (CL). The firm has a $94.00 price target on the stock. Bank of America reiterated its “buy” on shares of ...

View the full article

[ImmInst]

Knology (KNOL) (GERN) (SINA) (GNC) (GSM) (IFF) Price Targets Changed
Everything Gold - Nov 10, 2011

Knology, Inc. (NASDAQ: KNOL), Geron Co. (NASDAQ: GERN), Sina (NASDAQ: SINA), GNC Corp. (NYSE: GNC), Globe Specialty Metals, Inc. (NYSE: GSM) and International Flavors & Fragrances Inc. (NYSE: IFF ...

View the full article

[ImmInst]

Regenerative Medicine Universe Earnings Report Card Q3/11
Seeking Alpha - 4 hours ago

An earnings release is a "report card" of sorts for a public stem cell company. The current LPS (loss per share) standings reflect the universes' investing status. By analyzing these comparisons ...

View the full article

[ImmInst]

InVivo's Innovative Instigation In Spinal Cord Injury
Seeking Alpha - 6 hours ago

In the United States alone, 1,275,000 people are living with paralysis as a result of spinal cord injury (SCI). Each year, about 12,000 other people are added to that count [1]. In 1992, Mr. Frank ...

View the full article

[ImmInst]

Geron, LinkedIn, Symantec, Urban Outfitters: US Equity Preview
Bloomberg - 26 minutes ago

By Inyoung Hwang - Mon Nov 14 22:11:41 GMT 2011 Shares of the following companies may have unusual moves in US trading tomorrow. Stock symbols are in parentheses, and prices are as of 5 pm in New ...

View the full article

[ImmInst]

Geron to Focus on Its Novel Cancer Programs
MarketWatch - 1 hour ago

MENLO PARK, Calif., Nov 14, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN -3.51% today announced that, effective immediately, the Company will focus on its ...

Geron to shut down stem cell programs, shares fall - Reuters
Geron to halt stem-cell work - San Jose Mercury News
StreetInsider.com

View the full article

[ImmInst]

Follow From the Wires
Salon - 2 hours ago

MENLO PARK, Calif. (AP) — Money troubles have forced the first company doing a government-approved test of embryonic stem cell therapy to discontinue further stem cell programs and lay off much ...

View the full article

[ImmInst]

Follow From the Wires
Salon - 9 hours ago

By Linda A. Johnson, AP TRENTON, NJ (AP) — The company doing the first government-approved test of embryonic stem cell therapy is discontinuing further stem cell work, a move with stark ...

View the full article

[ImmInst]

Geron abandons pioneering stem cell program, lays off 66
FierceBiotech - 5 minutes ago

After more than a decade of pioneering work in the embryonic stem cell field, Geron ($GERN) has pulled out the white flag, abandoning its ESC work and laying off 66 workers as it scrambles to ...

View the full article

[ImmInst]

Geron Presents Final Phase 1 Clinical Data on GRN1005 at AACR-NCI-EORTC
MarketWatch - 27 minutes ago

MENLO PARK, Calif., Nov 15, 2011 (BUSINESS WIRE) -- Geron Corporation /quotes/zigman/55630/quotes/nls/gern GERN -3.51% today announced the final results of two Phase 1 clinical trials of GRN1005 ...

View the full article

[ImmInst]

Lack of Funds Halting Embryonic Stem Cells Trail
TopNews United States - 11 minutes ago

Lack of funding is causing hindrance in the path of world's first embryonic stem cells clinical trial. The trial was earlier begun at Geron, the US based company. As a part of the trial, the ...

View the full article

[ImmInst]

Geron shuts down world's first stem-cell trial
OCRegister - 1 hour ago

Geron Corp. is shutting down the world's first patient trial of a treatment involving human embryonic stem cells, citing lack of funding and economic difficulties. 53% off! $7 for $15 for Takeout ...

View the full article

[ImmInst]

Geron Discontinues hESC Programs
Patent Docs - 48 minutes ago

"Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition ...

View the full article

[ImmInst]

Geron To End Embryonic Stem Cell Research
NPR - 2 hours ago

Audio for this story from Talk of the Nation will be available at approx. 6:00 pm ET

View the full article

[ImmInst]

A Revealing Examination of the Strategy behind the Embryonic Stem Cell Hype
National Right to Life News - 3 hours ago

By Dave Andrusko Over the past three weeks we've discussed the fall-out from Geron Corporation's decision to get out of the embryonic stem cell research business altogether, despite knowledge that ...

View the full article

[ImmInst]

Has Geron Become the Perfect Stock?
DailyFinance - 13 hours ago

By Dan Caplinger, The Motley Fool Posted 9:49AM 12/08/11 Investing Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you ...

View the full article